Latest proposal is AbbVie's fifth attempt to lure Shire into a takeover since May, and would see Shire shareholders receive £24.44 a share in cash Source
The U.S. Drug maker says it will buy Irish-headquartered Shire in a cash and stock deal, according to reports by The Wall Street Journal and Bloomberg. Ref. USAToday
AbbVie to buy cancer biotech Pharmacyclics in $21B deal
AbbVie announced it has reached a deal to acquire the biopharmaceutical company Pharmacyclics in a $21 billion deal -- a mix of cash and stock for $261.25 a share. Ref. USAToday
This site uses Cookies to dispense or record information with regards to your visit. By continuing to use this site you agree to the terms outlined in ourCookies used here:Privacy / Disclaimer,